Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chiesi Farmaceutici S.p.A.
A Single-centre, Double-blind, Double-dummy, Randomised, Crossover Study to investigate the effect of Formoterol HFA-pMDI versus Salmeterol HFA-pMDI on small airways physiological parameters in COPD patients.
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a clinical diagnosis of COPD
Post bronchodilator FEV1 between 30% and 80% predicted values at screening
Post-bronchodilator FEV1/FVC \< 0.7
You may not be if
Positive FEV1 reversibility test: FEV1 change greater than 200 mL and 12%
History of another medical condition contraindicating participation in the study
